32 results
DEFA14A
ZOM
Zomedica Corp
20 Feb 24
Additional proxy soliciting materials
6:12am
at after a very lengthy and careful review of both historical and Zomedica-specific reverse split data with the following target goals:
1- Having
DEFA14A
ZOM
Zomedica Corp
24 Jan 24
Additional proxy soliciting materials
1:38pm
, looking beyond the reverse split, what are Zomedica’s primary goals and strategic initiatives for 2024, and how does the reverse split facilitate … profitability in future quarters.
Specifically, we are focused on a set of ambitious goals and strategic initiatives for 2024.
First, is to continue
8-K
EX-99.1
ijhcxnxekniegjvhp
4 Oct 21
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
6:15am
8-K
EX-99.1
ulp2phie
11 Aug 21
Zomedica Announces Second Quarter 2021 Financial Results
4:16pm
424B3
x3ja1k954n7k7
26 Oct 20
Prospectus supplement
9:21am
S-4/A
x5zmhp11dva7n
22 Oct 20
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
rqfn2e6pdn k44
9 Oct 20
Registration of securities issued in business combination transactions
1:57pm
PRE 14A
yreqr
29 Jul 20
Preliminary proxy
5:25pm